Imagine you are in a meadow in the rainforests of the Pacific Northwest. Imagine a whistle that blew the same exact pitch always and everywhere. Imagine self-steering immune cells that targeted and attacked tumors.
“When faced with becoming a single parent after nearly a decade of being mostly a stay-at-home mom, I had to decide if I was going to return to the food service industry and work my body to death while just paying the bills, or take a risk in trying to pursue a satisfying career I would be able to sustain passion for over the long haul. I chose the latter."
If you’d asked Molecular Cell Biology (MCB) student Eva Childers in her first year at Dartmouth about what it means to be a woman in science, she would have described a near optimal experience. As an undergraduate at Worchester Polytechnic Institute, Eva was enticed from her original plan to become a biomedical engineer into the world of biology and biotechnology by her research lab advisor, Amity Manning.
A recent article published by Dartmouth PhD candidate, Nicholas Warren, and his thesis advisor, Dr. Alan Eastman, demonstrates how a new class of drugs sensitize cancer cells to a standard chemotherapy.